AN2 Therapeutics, Inc. (ANTX)
NASDAQ·Healthcare·Biotechnology
$5.48
-3.69%
Mkt Cap $123.31M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$9.00
Range $9.00 – $9.00
Implied Upside
+64.2%
Consensus $9.00 vs current $5.48
NASDAQ·Healthcare·Biotechnology
$5.48
-3.69%
Mkt Cap $123.31M
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$9.00
Range $9.00 – $9.00
+64.2%
Consensus $9.00 vs current $5.48